Crossmark

Assessment of total carotid plaque area progression in patients with chronic kidney disease. Good practices for decision-making

Crossref DOI link: https://doi.org/10.1007/s40620-024-02146-9

Published Online: 2024-11-23

Published Print: 2025-01-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Porta, Daniela J.

Carrillo, Mariana N.

Pérez, Hernán A.

Rivoira, María A.

Ledesma, Grisel N.

Muñoz, Sonia E.

Aballay, Laura R.

Armando, Luis J.

Schelling, Jeffrey R.

Spence, J. David

García, Néstor H. https://orcid.org/0000-0002-9057-9030
Funding

Funding for this research was provided by:

Blossom DMO (SO 2017)

Non-Risk SA (NHH 2019)

Blossom DMO (SO 2017)

Non-Risk SA (NHH 2019)
License Information

Version of Record valid from 2024-11-23

Text and Data Mining valid from 2024-11-23

Version of Record valid from 2024-11-23
More Information

Article History

Received: 20 August 2024

Accepted: 24 October 2024

First Online: 23 November 2024

Declarations

:

: JDS receives small royalties on a share of a patent on the measurement of carotid plaque by 3D ultrasound; JDS and LJA are officers of a dormant corporation, Vascularis Inc. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

: The Institutional Committee for Ethical Evaluation of Health Research, National Clinical Hospital (CIEIS HNC-FCM) N°: 119/12, approved the protocol.

: Informed consent was waived by the Ethics Committee.

: The Institutional Committee for Ethical Evaluation of Health Research, National Clinical Hospital (CIEIS HNC-FCM) N°: 119/12, approved the protocol.